Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferation

Published:2021-06 Issue:9 Volume:35 Page:109156
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Puvvula Pavan Kumar,Yu Yao,Sullivan Kaelan Renaldo,Eyob Henok,Rozenberg Julian Markovich,Welm Alana,Huff Chad,Moon Anne M.

Funder

University of Utah

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference75 articles.

1. A new family of cyclophilins with an RNA recognition motif that interact with members of the trx/MLL protein family in Drosophila and human cells;Anderson;Dev. Genes Evol.,2002

2. Histone methylase MLL1 has critical roles in tumor growth and angiogenesis and its knockdown suppresses tumor growth in vivo;Ansari;Oncogene,2013

3. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality;Arkin;Chem. Biol.,2014

4. Gene ontology: tool for the unification of biology;Ashburner;Nat. Genet.,2000

5. The H3K4 methyltransferase Setd1a is first required at the epiblast stage, whereas Setd1b becomes essential after gastrulation;Bledau;Development,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RBM39 is a potential prognostic biomarker with functional significance in hepatocellular carcinoma;Translational Cancer Research;2024-04

2. LncRNA MCM3AP-AS1 promotes chemoresistance in triple-negative breast cancer through the miR-524-5p/RBM39 axis;Molecular and Cellular Biochemistry;2024-03-12

3. Discovery and characterization of anti-cancer peptides from a random peptide library;PLOS ONE;2024-02-13

4. De Novo Single-Stranded RNA-Binding Peptides Discovered by Codon-Restricted mRNA Display;Biomacromolecules;2023-12-05

5. Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathways;Scientific Reports;2023-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3